IT1212668B - Agente antiparkinsoniano a base di treo 3 4 diidrossifenilserina - Google Patents

Agente antiparkinsoniano a base di treo 3 4 diidrossifenilserina

Info

Publication number
IT1212668B
IT1212668B IT8268118A IT6811882A IT1212668B IT 1212668 B IT1212668 B IT 1212668B IT 8268118 A IT8268118 A IT 8268118A IT 6811882 A IT6811882 A IT 6811882A IT 1212668 B IT1212668 B IT 1212668B
Authority
IT
Italy
Prior art keywords
dihydroxyphenylserine
treo
antiparkinsonian agent
antiparkinsonian
agent
Prior art date
Application number
IT8268118A
Other languages
English (en)
Italian (it)
Other versions
IT8268118A0 (it
Inventor
Hirotaro Narabayashi
Tomoyoshi Kondo Akira Hayashi
Tomokazu Suzuki
Original Assignee
Sumitomo Chemical Co
Narabayashi Hirotarou
Kondo Tomoyoshi
Hayashi Akira
Tomokazu Suzuki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co, Narabayashi Hirotarou, Kondo Tomoyoshi, Hayashi Akira, Tomokazu Suzuki filed Critical Sumitomo Chemical Co
Publication of IT8268118A0 publication Critical patent/IT8268118A0/it
Application granted granted Critical
Publication of IT1212668B publication Critical patent/IT1212668B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8268118A 1981-09-22 1982-09-21 Agente antiparkinsoniano a base di treo 3 4 diidrossifenilserina IT1212668B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56150082A JPS5852219A (ja) 1981-09-22 1981-09-22 パ−キンソン病治療剤

Publications (2)

Publication Number Publication Date
IT8268118A0 IT8268118A0 (it) 1982-09-21
IT1212668B true IT1212668B (it) 1989-11-30

Family

ID=15489114

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8268118A IT1212668B (it) 1981-09-22 1982-09-21 Agente antiparkinsoniano a base di treo 3 4 diidrossifenilserina

Country Status (13)

Country Link
US (1) US4497826A (enExample)
JP (1) JPS5852219A (enExample)
AU (2) AU556542B2 (enExample)
BE (1) BE894451A (enExample)
CA (1) CA1184501A (enExample)
CH (1) CH650926A5 (enExample)
DE (1) DE3235093A1 (enExample)
FR (1) FR2513117B1 (enExample)
GB (1) GB2106388B (enExample)
IT (1) IT1212668B (enExample)
NL (1) NL189648C (enExample)
NZ (1) NZ201864A (enExample)
SE (1) SE462781B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6067420A (ja) * 1983-09-22 1985-04-17 Sumitomo Chem Co Ltd 精神運動興奮抑制剤
NZ209514A (en) * 1983-09-22 1988-03-30 Sumitomo Chemical Co Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor
AU575849B2 (en) * 1983-09-22 1988-08-11 Sumitomo Chemical Company, Limited Pharmaceutical composition and method for treatment of psychomotor excitement
JPS60132935A (ja) * 1983-12-20 1985-07-16 Sumitomo Chem Co Ltd フエニルセリン誘導体及びその製造方法
JPS6185318A (ja) * 1984-10-04 1986-04-30 Sumitomo Seiyaku Kk 利尿薬
ZA889189B (en) * 1986-06-16 1989-08-30 Merck & Co Inc Controlled release combination of carbidopa/levodopa
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4863962A (en) * 1988-03-02 1989-09-05 Fidia-Georgetown Institute For The Neurosciences D-DOPA, pharmaceutically acceptable salts thereof, and methods of treating Parkinson's disease
PT99864B (pt) * 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
DE4101873C2 (de) * 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
JP3559572B2 (ja) 1993-01-29 2004-09-02 住友製薬株式会社 急性痛および慢性痛用鎮痛剤
JP3764179B2 (ja) * 1994-07-05 2006-04-05 克寛 西野 運動・意識または言語障害の機能改善剤
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
GB2348371B (en) * 2000-03-14 2001-04-04 Soares Da Silva Patricio Compositions comprising blockers of L-DOPA renal cell transfer for the treatment of Parkinson's disease
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
WO2005025561A1 (en) * 2003-09-04 2005-03-24 Synergia Pharma, Inc. Compositions and methods for orthostatic intolerance
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US7786126B2 (en) * 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
DK1948155T3 (da) * 2006-06-28 2012-07-02 Chelsea Therapeutics Inc Farmaceutiske præparater omfattende droxidopa
ES2480966T3 (es) * 2007-03-09 2014-07-29 Chelsea Therapeutics, Inc. Droxidopa y composición farmacéutica de la misma para el tratamiento de la fibromialgia
AU2008248382B2 (en) * 2007-05-07 2013-07-18 Chelsea Therapeutics, Inc. Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders
US8580776B2 (en) * 2007-07-10 2013-11-12 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating neurodegenerating diseases
EP2450343A4 (en) 2009-07-01 2013-01-09 Dainippon Sumitomo Pharma Co PROCESS FOR PREPARING THREO-3- (3,4-DIHYDROXYPHENYL) L-SERIN
JP5880913B2 (ja) 2011-05-17 2016-03-09 三郎 佐古田 パーキンソン病の体幹症状（姿勢反射異常）の治療剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34275B1 (en) * 1969-06-18 1975-03-19 Merck & Co Inc Alpha-hydrazino acids
US3658968A (en) * 1970-06-11 1972-04-25 Merck & Co Inc Composition and method of treatment
DE2305209A1 (de) * 1972-02-14 1973-08-23 Hoffmann La Roche Pharmazeutisches praeparat
AU6889274A (en) * 1973-05-17 1975-11-20 Astra Laekemedel Ab Treatment of neurological disorders
CH580059A5 (enExample) * 1973-08-22 1976-09-30 Hoffmann La Roche
US3920728A (en) * 1973-08-22 1975-11-18 Hoffmann La Roche Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
JPS52125630A (en) * 1976-04-14 1977-10-21 Kyowa Hakko Kogyo Co Ltd Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS56104815A (en) * 1980-01-23 1981-08-20 Sumitomo Chem Co Ltd Remedy for peripheral orthostatic hypotension

Also Published As

Publication number Publication date
CA1184501A (en) 1985-03-26
NZ201864A (en) 1985-12-13
JPH0216284B2 (enExample) 1990-04-16
AU8857882A (en) 1983-03-31
NL189648C (nl) 1993-06-16
BE894451A (fr) 1983-03-21
SE462781B (sv) 1990-09-03
SE8205404D0 (sv) 1982-09-21
IT8268118A0 (it) 1982-09-21
JPS5852219A (ja) 1983-03-28
GB2106388B (en) 1986-03-26
FR2513117B1 (fr) 1986-01-24
AU556542B2 (en) 1986-11-06
NL189648B (nl) 1993-01-18
DE3235093C2 (enExample) 1988-12-29
FR2513117A1 (fr) 1983-03-25
DE3235093A1 (de) 1983-04-07
NL8203594A (nl) 1983-04-18
US4497826A (en) 1985-02-05
AU575267B2 (en) 1988-07-21
CH650926A5 (de) 1985-08-30
SE8205404L (sv) 1983-03-23
AU6750187A (en) 1987-04-16
GB2106388A (en) 1983-04-13

Similar Documents

Publication Publication Date Title
IT1212668B (it) Agente antiparkinsoniano a base di treo 3 4 diidrossifenilserina
IT1140502B (it) Agente di pulitura
IT8419374A0 (it) Agente antibroncopneumopatico.
DE3173535D1 (en) Use of 2,6,6-trimethyl-cyclohex-2-ene-1-yl-carboxylic-acid methyl ester as a perfuming agent
IT1205148B (it) Agente antistatico
TR21767A (tr) N-fenilsulfonil-n'-pirimidinil-ve-triazinilureler
DK554084D0 (da) 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol
JPS57161707A (en) 180 degree
FR2511712B1 (fr) Machine d'etirage
AT368725B (de) Kombinierte richt- und biegemaschine
IT1150191B (it) Agente di proliferazione per bifidobatteri
IT8222209A0 (it) Agenti anti-obesita'.
IT1203691B (it) Pesticidi a base di alchiltiofosfati aventi l'alchile alfa-ramificato
SU1179911A3 (ru) "пpomышлehhый poбot"
IT1226584B (it) Agente anti-iperlipemico
IT8183320A0 (it) Perfezionamenti ai dispositivi di impaccatura barre profilate e non e dispositivi di impaccatura barre profilate e non cosi' perfezionate.
ATA48482A (de) Bodenbearbeitungsmaschine
FI821159A0 (fi) 2,4-dioxacyclohexanonderivat
IT8106620A0 (it) Liomand 2000
IT8150816V0 (it) Equador 80
IT8108206A0 (it) Linotast 82
GB1542188A (en) 2,4-bis-(stilben-4-yl)v-triazoles and their use as optical brightening agents
IT1114244B (it) Agente antitumorale a base di composti nitrofurilvinilenici
IT8132827V0 (it) "for-meches"
IT8108920V0 (it) Salvacaffe'

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950929